IBM is making the IBM Clinical Development (IDC) system available free of charge to all countries affected with cases of Coronavirus, including Brazil.
IBM, through its Watson Health unit, is making the ICD system freely available to national health agencies for applicable clinical trials to help accelerate the development of drugs to combat COVID-19. The system is designed to reduce clinical trial time and cost by centralizing and organizing clinical trial information, providing 24/7 access to data via a single URL from any web-enabled device, and providing a platform flexible and scalable data management system.
IBM's software was first offered to Chinese health authorities, and as the disease spreads, IBM is now making it freely available to a wider network of national health agencies.
IBM has been selling this product for several years to clinical research institutions and organizations participating in clinical trials maintained by pharmaceutical and biotechnology companies — which may be healthcare systems, university hospitals, large medical clinics or individual researchers — for their research work. accompany clinical trials.
More information about the solution and access to the ICD is available here: http://www.ibm.com/blogs/ibm-comunica/ibm-fornece-gratuitamente-tecnologia-para-ajudar-a-combater-o-coronavirus/
Interactive Panel – IBM also offers free AI-powered interactive dashboard to easily track COVID-19 cases on your computer or smartphone.
To learn about IBM's COVID-19 initiatives, from education, to healthcare, government assistance and more, visit: iBm.çOm/tHOugHt–landThedandrsHiP/çOv
EN 
PT 
